Maria Claudia Burgos Florez

ORCID: 0000-0003-0367-0264
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • Herpesvirus Infections and Treatments
  • Viral Infections and Outbreaks Research
  • Viral Infections and Vectors
  • Monoclonal and Polyclonal Antibodies Research
  • Pneumonia and Respiratory Infections
  • HIV Research and Treatment
  • Virus-based gene therapy research
  • vaccines and immunoinformatics approaches
  • Transgenic Plants and Applications

National Institute of Allergy and Infectious Diseases
2019-2024

National Institutes of Health
2019-2024

Alicia T. Widge Amelia R. Hofstetter Katherine V. Houser Seemal F. Awan Grace Chen and 95 more Maria Claudia Burgos Florez Nina M. Berkowitz Floreliz Mendoza Cynthia S. Hendel LaSonji A. Holman Ingelise J. Gordon Preeti Apte C. Jason Liang Martin R. Gaudinski Emily E. Coates Larisa Strom Diane Wycuff Sandra Vazquez Judy Stein Jason G. Gall William C. Adams Kevin Carlton Rebecca A. Gillespie Adrian Creanga Michelle C. Crank Sarah F. Andrews Mike Castro Leonid Serebryannyy Sandeep Narpala Christian Hatcher Bob C. Lin Sarah O’Connell Alec W. Freyn Victoria Rosado Raffael Nachbagauer Peter Palese Masaru Kanekiyo Adrian B. McDermott Richard A. Koup Lesia K. Dropulic Barney S. Graham John R. Mascola Julie E. Ledgerwood Allison Beck Joseph P. Casazza Christopher L. Case John Misasi Abidemi O. Ola Karen Parker Richard Wu Pamela Costner Jamie Saunders Laura Novik William Whalen Xiaolin Wang Aba Mensima Eshun Jennifer Cunningham Anita Arthur Morgan Anderson Justine Jones Brenda Larkin Thuy Nguyen Sandra Sitar Lam Le Iris Pittman Olga Vasilenko Galina V. Yamshchikov Ro Shauna Rothwell Eugenia Burch Olga Trofymenko Sarah H. Plummer Catina Evans Cora Trelles Cartagena Renunda Hicks LaShawn Requilman Pernell Williams Carmencita Graves Shinyi Telscher Gabriela Albright Jessica Bahorich Sashikanth Banappagari Michael Bender Alegria T. Caringal Juliane Guimarães de Carvalho Rajoshi Chaudhuri Mythili Chintamani Jonathan W. Cooper Jacob Demirji Tracey Dinh G Dobrescu Alvenne Goh Deepika Gollapudi Raju Gottumukkala Daniel B. Gowetski Janel Holland-Linn Jin Hong Joe Horwitz Vera B. Ivleva Lisa A. Kueltzo Nadji Lambert

Influenza vaccines could be improved by platforms inducing cross-reactive immunity. Immunodominance of the influenza hemagglutinin (HA) head in currently licensed impedes induction neutralizing stem-directed antibodies. A vaccine without variable HA domain has potential to focus immune response on conserved stem. This first-in-human dose-escalation open-label phase 1 clinical trial (NCT03814720) tested an stabilized stem ferritin nanoparticle (H1ssF) based H1 A/New Caledonia/20/1999....

10.1126/scitranslmed.ade4790 article EN Science Translational Medicine 2023-04-19

10.1038/s41591-022-01762-x article EN Nature Medicine 2022-04-11

10.1016/s2213-2600(21)00098-9 article EN The Lancet Respiratory Medicine 2021-04-15
Coming Soon ...